Atlas Trials

Temozolomide Chronotherapy for High Grade Glioma

Clinical trial NCT02781792 · COMPLETED

Trial details

NCT number
NCT02781792
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GliomaGlioblastoma Multiforme
Start date
2016-08-11
Primary completion
2024-07-18
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.